BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheemerla S, Balakrishnan M. Global Epidemiology of Chronic Liver Disease. Clin Liver Dis (Hoboken) 2021;17:365-70. [PMID: 34136143 DOI: 10.1002/cld.1061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Pavic T, Mikolasevic I, Kralj D, Blazevic N, Skrtic A, Budimir I, Lerotic I, Hrabar D. Role of Endoscopic Ultrasound in Liver Disease: Where Do We Stand? Diagnostics (Basel) 2021;11:2021. [PMID: 34829368 DOI: 10.3390/diagnostics11112021] [Reference Citation Analysis]
2 Sherk A, Esser MB, Stockwell T, Naimi TS. Estimating alcohol-attributable liver disease mortality: A comparison of methods. Drug Alcohol Rev 2022. [PMID: 35363378 DOI: 10.1111/dar.13470] [Reference Citation Analysis]
3 Vazirzadeh M, Azarpira N, Davoodi P, Vosough M, Ghaedi K. Natural Scaffolds Used for Liver Regeneration: A Narrative Update. Stem Cell Rev Rep 2022. [PMID: 35320512 DOI: 10.1007/s12015-022-10362-8] [Reference Citation Analysis]
4 Dubey SR, Ashavaid TF, Abraham P, Paradkar MU. Factors influencing circulating microRNAs as biomarkers for liver diseases. Mol Biol Rep. [DOI: 10.1007/s11033-022-07170-1] [Reference Citation Analysis]
5 Labenz C, Arslanow A, Nguyen-Tat M, Nagel M, Wörns MA, Reichert MC, Heil FJ, Mainz D, Zimper G, Römer B, Binder H, Farin-Glattacker E, Fichtner U, Graf E, Stelzer D, Van Ewijk R, Ortner J, Velthuis L, Lammert F, Galle PR. Structured Early detection of Asymptomatic Liver Cirrhosis: Results of the population-based liver screening program SEAL. J Hepatol 2022:S0168-8278(22)00244-6. [PMID: 35472313 DOI: 10.1016/j.jhep.2022.04.009] [Reference Citation Analysis]
6 Tamargo JA, Sherman KE, Sékaly RP, Bordi R, Schlatzer D, Lai S, Khalsa JH, Mandler RN, Ehman RL, Baum MK. Cocaethylene, simultaneous alcohol and cocaine use, and liver fibrosis in people living with and without HIV. Drug Alcohol Depend 2022;232:109273. [PMID: 35033954 DOI: 10.1016/j.drugalcdep.2022.109273] [Reference Citation Analysis]
7 Dai Q, Jiang W, Huang F, Song F, Zhang J, Zhao H. Recent Advances in Liver Engineering With Decellularized Scaffold. Front Bioeng Biotechnol 2022;10:831477. [DOI: 10.3389/fbioe.2022.831477] [Reference Citation Analysis]
8 Tesfaye BT, Feyissa TM, Workneh AB, Gudina EK, Yizengaw MA. Chronic Liver Disease in Ethiopia with a Particular Focus on the Etiological Spectrums: A Systematic Review and Meta-Analysis of Observational Studies. Can J Gastroenterol Hepatol 2021;2021:8740157. [PMID: 34858892 DOI: 10.1155/2021/8740157] [Reference Citation Analysis]
9 Yin Y, Yakar D, Dierckx RAJO, Mouridsen KB, Kwee TC, de Haas RJ. Combining Hepatic and Splenic CT Radiomic Features Improves Radiomic Analysis Performance for Liver Fibrosis Staging. Diagnostics (Basel) 2022;12:550. [PMID: 35204639 DOI: 10.3390/diagnostics12020550] [Reference Citation Analysis]
10 Getachew A, Hussain M, Huang X, Li Y. Toll-like receptor 2 signaling in liver pathophysiology. Life Sci 2021;284:119941. [PMID: 34508761 DOI: 10.1016/j.lfs.2021.119941] [Reference Citation Analysis]